| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013322747 |
| P356 | DOI | 10.1186/CC9387 |
| P932 | PMC publication ID | 3219978 |
| P698 | PubMed publication ID | 21182783 |
| P5875 | ResearchGate publication ID | 49706516 |
| P50 | author | Hugo Van Aken | Q14508140 |
| Giovanni Landoni | Q56670236 | ||
| P2093 | author name string | Can Ince | |
| Jean-Louis Teboul | |||
| Alessandra Orecchioni | |||
| Andrea Morelli | |||
| Paolo Pelaia | |||
| Paolo Pietropaoli | |||
| Matthias Lange | |||
| Christian Ertmer | |||
| Martin Westphal | |||
| Sebastian Rehberg | |||
| Abele Donati | |||
| Valeria Cecchini | |||
| P2860 | cites work | Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study | Q79687127 |
| Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study | Q79767745 | ||
| Myocardial depression associated with pneumococcal septic shock reversed by levosimendan | Q80525790 | ||
| Levosimendan in septic shock: a case series | Q80804374 | ||
| How to evaluate the microcirculation: report of a round table conference | Q22000127 | ||
| Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 | Q29615602 | ||
| Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials | Q30489561 | ||
| Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock | Q30711418 | ||
| Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression | Q31157664 | ||
| The pathogenesis of vasodilatory shock | Q34350541 | ||
| Opening the microcirculation: can vasodilators be useful in sepsis? | Q34810464 | ||
| Levosimendan, a new inotropic and vasodilator agent | Q36409776 | ||
| Levosimendan: beyond its simple inotropic effect in heart failure | Q36760756 | ||
| Role of levosimendan in sepsis and septic shock | Q37149823 | ||
| Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. | Q42958949 | ||
| Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock. | Q43227030 | ||
| Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. | Q43793616 | ||
| Dobutamine and gastric-to-arterial carbon dioxide gap in severe sepsis without shock | Q43924226 | ||
| Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial | Q44652413 | ||
| Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study | Q44986442 | ||
| Levosimendan in septic cardiac failure | Q45174191 | ||
| Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs | Q45220187 | ||
| Successful reversal of resistent hypodynamic septic shock with levosimendan | Q45241668 | ||
| Effects of intravenous and inhaled levosimendan in severe rodent sepsis | Q46050849 | ||
| Effects of levosimendan and dobutamine on experimental acute lung injury in rats | Q46232691 | ||
| Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury | Q46582094 | ||
| Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock. | Q46582114 | ||
| Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits | Q46676189 | ||
| The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects | Q46902596 | ||
| Cardiovascular effects of levosimendan in the early stages of endotoxemia. | Q54441177 | ||
| Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone | Q61842194 | ||
| A Dobutamine Test Can Disclose Hepatosplanchnic Hypoperfusion in Septic Patients | Q64127223 | ||
| Adjusting for baseline: change or percentage change? | Q69552399 | ||
| Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock | Q73030062 | ||
| Nitroglycerin in septic shock after intravascular volume resuscitation | Q78494402 | ||
| P433 | issue | 6 | |
| P921 | main subject | sepsis | Q183134 |
| septic shock | Q1765564 | ||
| resuscitation | Q5491454 | ||
| P304 | page(s) | R232 | |
| P577 | publication date | 2010-12-23 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study | |
| P478 | volume | 14 |
| Q88990260 | A global perspective on vasoactive agents in shock |
| Q33770902 | An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial. |
| Q36148874 | Association of Microcirculation, Macrocirculation, and Severity of Illness in Septic Shock: A Prospective Observational Study to Identify Microcirculatory Targets Potentially Suitable for Guidance of Hemodynamic Therapy |
| Q42653967 | Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials |
| Q38021511 | Biomarkers and clinical tools in critically ill children: are we heading toward tailored drug therapy? |
| Q83592839 | Changes in the sublingual microcirculation and endothelial adhesion molecules during the course of severe meningococcal disease treated in the paediatric intensive care unit |
| Q34500356 | Clinical assessment of peripheral perfusion to predict postoperative complications after major abdominal surgery early: a prospective observational study in adults |
| Q46688142 | Clinical relevance of early sublingual microcirculation monitoring in septic shock patients |
| Q91741502 | Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials |
| Q64055906 | Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials |
| Q42153345 | Comparison of different methods for the calculation of the microvascular flow index |
| Q42077666 | Decatecholaminization and calcium sensitizers in critically ill patients |
| Q28069337 | Early prevention of trauma-related infection/sepsis |
| Q53833665 | Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials. |
| Q40176981 | Effect of small-dose levosimendan on mortality rates and organ functions in Chinese elderly patients with sepsis |
| Q30490959 | Effects of Levosimendan on Cellular Metabolic Alterations in Patients with Septic Shock: A Randomized Controlled Pilot Study. |
| Q43545711 | Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. |
| Q38292123 | Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis |
| Q47113590 | Effects of levosimendan on mortality in patients with septic shock: systematic review with meta-analysis and trial sequential analysis |
| Q35908131 | Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock |
| Q42258423 | From macrohemodynamic to the microcirculation |
| Q39475893 | Impact of microcirculatory video quality on the evaluation of sublingual microcirculation in critically ill patients |
| Q97544791 | Inodilators in septic shock: should these be used? |
| Q24201225 | Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome |
| Q24203783 | Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome |
| Q43042702 | Isoproterenol infusion and microcirculation in septic shock. |
| Q36148005 | Levosimendan Administration in Limb Ischemia: Multicomponent Signaling Serving Kidney Protection |
| Q97884755 | Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use |
| Q36883306 | Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial |
| Q64947650 | Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. |
| Q34761833 | Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model |
| Q26738701 | Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper |
| Q38191912 | Levosimendan in critical illness: a literature review. |
| Q36070389 | Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study |
| Q24629274 | Levosimendan: current data, clinical use and future development |
| Q26798312 | Microcirculatory dysfunction and resuscitation: why, when, and how |
| Q38815302 | Microcirculatory dysfunction in sepsis: pathophysiology, clinical monitoring, and potential therapies |
| Q47440269 | Misinterpretation of the sublingual microcirculation during therapy with levosimendan |
| Q38029553 | Monitoring the microcirculation |
| Q26851227 | Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock |
| Q37978478 | Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury |
| Q55041662 | Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure. |
| Q37670488 | Sepsis and Immunosenescence in the Elderly Patient: A Review |
| Q30251753 | Sepsis: in search of cure. |
| Q90446344 | Shock - Classification and Pathophysiological Principles of Therapeutics |
| Q47782870 | Sidestream dark field videomicroscopy for in vivo evaluation of vascularization and perfusion of mammary tumours in HER2/neu transgenic mice |
| Q39607860 | Study Design of the Microcirculatory Shock Occurrence in Acutely Ill Patients (microSOAP): an International Multicenter Observational Study of Sublingual Microcirculatory Alterations in Intensive Care Patients |
| Q29615429 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 |
| Q35107094 | The Japanese guidelines for the management of sepsis |
| Q36088227 | To beta block or not to beta block; that is the question |
| Q38091521 | Towards integrative physiological monitoring of the critically ill: from cardiovascular to microcirculatory and cellular function monitoring at the bedside. |
| Q54254903 | Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates. |
| Q60950194 | Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper |
| Q28068818 | Vasoactive agents for the treatment of sepsis |
| Q35010187 | Visualizing the cortical microcirculation in patients with stroke |
| Q37966024 | Year in review 2010: Critical Care--Cardiology |
Search more.